Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathwayKoji Ishida, Hitoshi Yoshiji|The Journal of Nutritional Biochemistry|2020Cited by 87
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic miceSatoshi Iwai, Hitoshi Yoshiji|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2023Cited by 45
TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic RatsDaisuke Kaya, Hitoshi Yoshiji|Cells|2019Cited by 27
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic SteatohepatitisYuki Tsuji, Hitoshi Yoshiji|Microorganisms|2020Cited by 24
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axisKōji Murata, Hitoshi Yoshiji|International Journal of Molecular Medicine|2022Cited by 20